Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Kimmel

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 8, 2015
Warfarin pharmacogenomics: current best evidenceS E Kimmel
The American Journal of Cardiology|July 19, 2000
Sex and myocardial infarction: an epidemiologic perspectiveS E Kimmel
Journal of General Internal Medicine|December 1, 1995
Smoking cessation and the nicotine patch: much more to be doneS E Kimmel, N Benowitz
Cerebrovascular Diseases (Basel, Switzerland)|January 12, 2000
Accuracy of initial stroke subtype diagnosis. a decision analysisS E Kasner, S E Kimmel
Hospital Practice (1995)|July 15, 1996
Calcium channel blockers and hypertension: 1. New trialsR R Townsend, S E Kimmel
Current Opinion in Cardiology|July 1, 1996
Calcium-channel blockers in ischemic heart diseaseF E Silvestry, S E Kimmel
Pharmacoepidemiology and Drug Safety|November 26, 2008
The calcium-channel blocker controversy: historical perspective and important lessons for future pharmacotherapies. An international society of pharmacoepidemiology 'hot topic'J R Kizer, S E Kimmel
Archives of Internal Medicine|May 18, 2001
Epidemiologic review of the calcium channel blocker drugs. An up-to-date perspective on the proposed hazardsJ R Kizer, S E Kimmel
Journal of the American College of Cardiology|October 8, 1997
Operator volume as a "risk factor"S E Kimmel, D M Kolansky
Journal of General Internal Medicine|September 19, 1997
Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?M A Scheiner, S E Kimmel
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Haemostasis : JTH|July 8, 2015
Warfarin pharmacogenomics: current best evidenceS E Kimmel
The American Journal of Cardiology|July 19, 2000
Sex and myocardial infarction: an epidemiologic perspectiveS E Kimmel
Journal of General Internal Medicine|December 1, 1995
Smoking cessation and the nicotine patch: much more to be doneS E Kimmel, N Benowitz
Cerebrovascular Diseases (Basel, Switzerland)|January 12, 2000
Accuracy of initial stroke subtype diagnosis. a decision analysisS E Kasner, S E Kimmel
Hospital Practice (1995)|July 15, 1996
Calcium channel blockers and hypertension: 1. New trialsR R Townsend, S E Kimmel
Current Opinion in Cardiology|July 1, 1996
Calcium-channel blockers in ischemic heart diseaseF E Silvestry, S E Kimmel
Pharmacoepidemiology and Drug Safety|November 26, 2008
The calcium-channel blocker controversy: historical perspective and important lessons for future pharmacotherapies. An international society of pharmacoepidemiology 'hot topic'J R Kizer, S E Kimmel
Archives of Internal Medicine|May 18, 2001
Epidemiologic review of the calcium channel blocker drugs. An up-to-date perspective on the proposed hazardsJ R Kizer, S E Kimmel
Journal of the American College of Cardiology|October 8, 1997
Operator volume as a "risk factor"S E Kimmel, D M Kolansky
Journal of General Internal Medicine|September 19, 1997
Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?M A Scheiner, S E Kimmel
Pageof 6